FR2267113B1 - - Google Patents

Info

Publication number
FR2267113B1
FR2267113B1 FR7511397A FR7511397A FR2267113B1 FR 2267113 B1 FR2267113 B1 FR 2267113B1 FR 7511397 A FR7511397 A FR 7511397A FR 7511397 A FR7511397 A FR 7511397A FR 2267113 B1 FR2267113 B1 FR 2267113B1
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR7511397A
Other languages
French (fr)
Other versions
FR2267113A1 (it
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
ER Squibb and Sons LLC
Original Assignee
ER Squibb and Sons LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ER Squibb and Sons LLC filed Critical ER Squibb and Sons LLC
Publication of FR2267113A1 publication Critical patent/FR2267113A1/fr
Application granted granted Critical
Publication of FR2267113B1 publication Critical patent/FR2267113B1/fr
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/745—Blood coagulation or fibrinolysis factors
    • C07K14/755—Factors VIII, e.g. factor VIII C (AHF), factor VIII Ag (VWF)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Epidemiology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
FR7511397A 1974-04-12 1975-04-11 Expired FR2267113B1 (it)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US46041774A 1974-04-12 1974-04-12

Publications (2)

Publication Number Publication Date
FR2267113A1 FR2267113A1 (it) 1975-11-07
FR2267113B1 true FR2267113B1 (it) 1979-08-24

Family

ID=23828619

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7511397A Expired FR2267113B1 (it) 1974-04-12 1975-04-11

Country Status (5)

Country Link
JP (1) JPS50142719A (it)
CA (1) CA1045032A (it)
DE (1) DE2516186A1 (it)
FR (1) FR2267113B1 (it)
GB (1) GB1507198A (it)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2624373C2 (de) * 1976-05-31 1983-02-03 Arnold Dr. 8782 Karlstadt Seufert Verfahren zur Herstellung von steril filtriertem Kryopräzipilat mit einer Anreicherung des Faktors VIII
CA1054052A (en) * 1976-08-14 1979-05-08 Edward Shanbrom Simplified method for preparation of high yield, high purity factor viii concentrate
US4302445A (en) * 1980-01-18 1981-11-24 Institut Merieux Method for concentrating and purifying antihemophilic factor or factor VIII
JPS5867627A (ja) * 1981-10-12 1983-04-22 ア−マ−・フア−マシユ−テイカル・カンパニ− 高純度抗血友病性因子の製造法
DE3318521A1 (de) * 1983-05-20 1984-11-22 Lentia GmbH Chem. u. pharm. Erzeugnisse - Industriebedarf, 8000 München Verfahren zur herstellung eines antihaemophiliefaktor-konzentrats
AU6487286A (en) * 1985-11-08 1987-05-14 Baxter Travenol Laboratories Inc. Antihemophilic factor by cold precipitation

Also Published As

Publication number Publication date
JPS50142719A (it) 1975-11-17
GB1507198A (en) 1978-04-12
DE2516186A1 (de) 1975-10-30
CA1045032A (en) 1978-12-26
FR2267113A1 (it) 1975-11-07

Similar Documents

Publication Publication Date Title
BR7501663A (it)
FR2265886B1 (it)
AU495028B2 (it)
AU479931A (it)
AU480469A (it)
AU480925A (it)
AU481219A (it)
AU481663A (it)
AU481934A (it)
BG19564A1 (it)
BG19694A1 (it)
BG19714A1 (it)
BG19878A1 (it)
BG19899A1 (it)
BG19972A1 (it)
BG20225A1 (it)
BG20230A1 (it)
BG20474A1 (it)
BG20476A1 (it)
BG20685A1 (it)
BG20866A1 (it)
BG20941A1 (it)
BG21080A1 (it)
BG21122A1 (it)
BG21132A1 (it)

Legal Events

Date Code Title Description
ST Notification of lapse